203. Activity of Cefepime in Combination with Taniborbactam (formerly VNRX-5133) Against Pseudomonas aeruginosa from a Global 2018-2020 Surveillance Collection

BACKGROUND: Taniborbactam is a novel cyclic boronate-based broad-spectrum β-lactamase inhibitor (BLI) with potent and selective inhibitory activity against both serine- and metallo-β-lactamases (MBLs). Taniborbactam restores the activity of cefepime (FEP) against many multidrug resistant organisms,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackel, Meredith, Wise, Mark G G, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644140/
http://dx.doi.org/10.1093/ofid/ofab466.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644140/
http://dx.doi.org/10.1093/ofid/ofab466.203

Ejemplares similares